Cargando…
Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability
Because Eplerenone (EPL) is a Biopharmaceutical Classification System (BCS) class-II drug and is prone to extensive liver degradation, it suffers from poor bioavailability after oral administration. This work aimed to prepare liquisolids loaded with EPL-nanoemulsions (EPL-NEs) that have a higher dru...
Autor principal: | Khames, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358907/ https://www.ncbi.nlm.nih.gov/pubmed/30669353 http://dx.doi.org/10.3390/pharmaceutics11010040 |
Ejemplares similares
-
Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique
por: Khames, Ahmed
Publicado: (2017) -
Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability
por: Patel, Yomesh, et al.
Publicado: (2012) -
Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability
por: Khan, Muhammad Ayub, et al.
Publicado: (2021) -
Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design
por: Vittal, G Vijayaranga, et al.
Publicado: (2012) -
Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
por: Prajapati, Shailesh T., et al.
Publicado: (2013)